Clinical Trial Update: Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals [Phase 1]

View source ↗

Summary

A Phase 1 single- and multiple-ascending-dose study of MTR-601 in healthy individuals has completed, assessing safety and pharmacokinetics across planned dose r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Dystonia
• Hereditary Spastic Paraplegia
• Multiple Sclerosis
• Spinal Cord Injury
• Stroke

Drugs mentioned

• MTR-601

Snippet

Sponsor: Motric Bio | Conditions: Muscle Spasticity, Hypertonia, Muscle | Phase 1 | Status: COMPLETED